Company Overview and News

1
Converge ICT to partner with KT for 3rd telco bid

2018-10-15 bworldonline
THE Department of Information and Communications Technology (DICT) said Converge ICT Solutions, Inc. has committed to joining the government’s bid for a new telecommunications player, with South Korean telecommunications giant KT Corp. as its partner.
K3ED CHJHF NOW KT CHA 0728 DNOW

1
China Telecom buys bid documents for ‘third player’ selection

2018-10-12 bworldonline
CHINA Telecom Corp. Ltd. became the second foreign company to buy bid documents to become the telecommunications industry’s third entrant — the so-called “third player” — with the selection process also getting a boost after a Manila court denied a petition for a temporary restraining order (TRO) by a participant questioning the bid terms.
K3ED CHJHF NOW CHA 0728 DNOW

1
Bargain hunt makes PSEi bounce back above 7,000

2018-10-12 bworldonline
THE MAIN INDEX clawed its way back above the 7,000 mark on Friday from Thursday’s worst year-to-date finish on bargain hunting and signs that Sino-US trade tensions could ease.
SVTMF NOW GTMEY SM AEV SECB SMIVY SSI JBFCF MWP PHSXY GTMEF PSE SPHXF MWIDE SPHZF GLOPA UVRBF AYAAF PSKXF AYAAY JBFCY UVRBY GLOPP SMPH GLO ABTZY SPHXY SYBJF JFC URC DNOW ALI

1
PSE index hits lowest since early January

2018-10-11 business.inquirer.net
The local stock barometer slid below the critical 7,000 support level yesterday as foreigners dumped local equities for the 31st straight trading day amid a global bloodbath widely described as “Red October.”
PSKXF NOW BDOUY AYAAY SECB BDOUF BDO SYBJF PHSXY PSE DNOW ALI AYAAF

1
NOW stock price continues to fall as firm’s actions confuse investors

2018-10-11 business.inquirer.net
Listed technology firm NOW Corp., once the darling of stock market speculators betting on the government’s third telco initiative, continued its losing streak yesterday.
GLO NOW GTMEY GTMEF GLOPP GLOPA DNOW

1
Investors hurting as NOW Corp. continues free fall

2018-10-11 business.inquirer.net
Listed technology company NOW Corp., once the darling of stock market speculators betting on the government’s third telco initiative, continued its losing streak on Thursday.
NOW DNOW

1
Aspiring 3rd telco balks at financial requirements, sues NTC

2018-10-09 business.inquirer.net
The Duterte administration’s third telco initiative received its first legal challenge a day after bidders were invited to participate, catching interested parties and the general public off-guard while casting a cloud over a selection process aimed at breaking the PLDT Inc. and Globe Telecom duopoly.
GLO NOW GTMEY GTMEF GLOPP GLOPA DNOW

1
NTC sued over alleged “money making schemes” in third telco search

2018-10-09 bworldonline
NOW Telecom, an affiliate of local telecommunications, media, and technology company NOW Corporation, filed a case against the National Telecommunications Commission (NTC) on October 8. This is over claims of legal violations in the New Major Player Terms of Reference by NTC and the Department of Information and Communications Technology (DICT).
NOW DNOW

2
Muted foreign interest in 3rd telco slot

2018-10-08 bworldonline - 1
FOUR LOCAL FIRMS and only one foreign company, Norway’s Telenor Group, firmed up their interest in participating in the auction for the country’s third major telecommunications service provider by purchasing the bid documents on Monday — the first day of its availability.
K3ED CHJHF NOW GTMEY CHA ECP GLOPP GLO KT 0728 GTMEF GLOPA DNOW

3
‘Serious’ query from Vodafone about 3rd player auction — Diokno

2018-10-03 bworldonline - 1
THE UK’s Vodafone Group PLC has discussed with the government the possibility of participating in the selection process for the telecommunications industry’s so-called “third player,” Budget Secretary Benjamin E. Diokno said following a visit to London.
K3ED VOD CHJHF VOD VODPF NOW KT CHA 0728 ECP DNOW

1
3rd telco player known next month

2018-10-02 business.inquirer.net
The Department of Information and Communications Technology (DICT) firmed up the deadline for the selection of a new major telco player in November this year.
GLO NOW GTMEY GTMEF ECP GLOPP GLOPA DNOW

1
Final timetable for 3rd major telco set

2018-10-02 bworldonline
THE DEPARTMENT of Information and Communications Technology (DICT) presented on Tuesday the final timetable for selection of the country’s third major telecommunications service provider, with documents available for purchase by interested parties starting Oct. 8, Monday.
K3ED CHJHF NOW GTMEY CHA ECP GLOPP GLO KT 0728 GTMEF GLOPA DNOW

1
Telenor in talks with potential partners to enter PHL market

2018-09-30 bworldonline
NORWAY’S Telenor Group said it is in talks with local companies as it eyes participation in the bidding for the third player slot in the Philippine telco industry.
K3ED CHJHF NOW GTMEY CHA ECP GLOPP GLO KT 0728 GTMEF GLOPA DNOW

7
EIA Reports Shock Inventory Increase on Lower Refinery Runs

2018-09-27 zacks
The U.S. Energy Department's inventory release showed that crude stockpiles recorded a shock weekly build on plunging refinery utilization. On a further bearish note, gasoline inventories increased, while domestic oil production hit a new record. As a result, the front month West Texas Intermediate (WTI) crude futures moved down 1% (or 71 cents) to end at $71.57 per barrel yesterday.
COP GFN GFNCP NOW PSX CVX VLO GFDV MPC DNOW GFNSL

2
NOW Inc. Has A Steady Growth Path, But Lacks Exuberance

2018-09-25 seekingalpha
NOW Inc. (DNOW) distributes maintenance, repair, and operating (or MRO) supplies to the upstream, midstream, and downstream industries. It also distributes to other industries including manufacturing, aerospace, automotive, refineries and engineering, and construction firms. The energy market growth will continue to pull DNOW's revenues higher, and DNOW has a flexible operating model to benefit from value-added services.
[DXPE] DXPE NOW DNOW MRC

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to PSE:NOW / Now Corporation on message board site Silicon Investor.

The unknown zone The unknown zone The unknown zone ServiceNow, Inc. ServiceNow, Inc. ServiceNow, Inc.
Autodesk (ADSK), sales now increasing! Autodesk (ADSK), sales now increasing! Autodesk (ADSK), sales now increasing! Retirement - Now what? Retirement - Now what? Retirement - Now what?
Market crash like NOW Market crash like NOW Market crash like NOW Aixtron AIXG now listed on the NASDAQ after GGNS merger Aixtron AIXG now listed on the NASDAQ after GGNS merger Aixtron AIXG now listed on the NASDAQ after GGNS merger
Texas Instruments - Good buy now or should we wait? Texas Instruments - Good buy now or should we wait? Texas Instruments - Good buy now or should we wait? Knowledge Extraction Technologies Knowledge Extraction Technologies Knowledge Extraction Technologies
American MultiPlexer (AMUT) -- Cheap Now, But for How Long American MultiPlexer (AMUT) -- Cheap Now, But for How Long American MultiPlexer (AMUT) -- Cheap Now, But for How Long Edward Snowden: Traitor, or National Hero? Edward Snowden: Traitor, or National Hero? Edward Snowden: Traitor, or National Hero?